SCHEMBL9811075

SCHEMBL9811075

Nc1ccc2c(c1)Cc1c(F)cccc1-2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
MAPT P10636 3/20 0.58
RAB9A P51151 3/20 0.58
NPC1 O15118 2/20 0.58
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
KDM4E B2RXH2 1/20 0.58
HPGD P15428 1/20 0.58
PGR P06401 2/20 0.44
PARP1 P09874 2/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TLR9 Q9NR96 1/20 0.41
GAA P10253 1/20 0.39
HSP90AA1 P07900 1/20 0.38
PNMT P11086 1/20 0.38
NOS3 P29474 1/20 0.37
NOS2 P35228 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27857062 0.82 RAB9A (0.61) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL9811064 0.82 CA1 (0.47) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL14174171 0.80 RAB9A (0.81) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL27821704 0.80 NPC1 (0.59) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL24727268 0.79 PGR (0.50) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL12535984 0.79 LMNA (0.58) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL4359047 0.77 PNMT (0.53) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL6651652 0.77 LMNA (0.46) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL6701148 0.76 MAPT (0.58) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL5684576 0.74 PGR (0.47) PGRPNMTNOS3NOS2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 US disclosed
US-4438272-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1984-03-20 US disclosed
US-4436745-A TETRACYCLIC SPIROHYDANTOINS ALCON LABORATORIES, INC. (US) 1984-03-13 US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 WO disclosed